Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
By Company
Sanofi
Techdow (Hepalink)
Teva
Nanjing King-friend
Rovi
Fresenius Kabi
Fosun Pharma(Gland Pharma)
Amphastar
Sandoz (Novartis)
Apotex
Huadong Medicine
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Segment by Sales Channel
Hospital & Clinic
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Spain
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Eqypt
South Africa
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.
The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
By Company
Sanofi
Techdow (Hepalink)
Teva
Nanjing King-friend
Rovi
Fresenius Kabi
Fosun Pharma(Gland Pharma)
Amphastar
Sandoz (Novartis)
Apotex
Huadong Medicine
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Segment by Sales Channel
Hospital & Clinic
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Spain
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Eqypt
South Africa
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
